甲氨蝶呤联合米非司酮在内生型早期剖宫产瘢痕妊娠治疗中的价值分析

摘要

Objective To analyze the value of methotrexate combined mifepristone in treatment of early cesarean scar pregnancy. Methods Our hospital from September 2013 to September 2015 admitted during the period of 60 patients with endogenous type cesarean scar pregnancy early as the research object, and randomly divided into treatment group and control group,control group treated with methotrexate,joint mifepristone treatment,treatment group on the basis of the analysis of therapeutic effect. Results The total effective rate in treatment group was significantly higher than the control group, compared with significant difference was statistical y significant(P<0.05). Conclusion For patients with endogenous type cesarean scar pregnancy early,taking methotrexate combined mifepristone treatment effect significantly,higher clinical value.%目的：分析甲氨蝶呤联合米非司酮在内生型早期剖宫产瘢痕妊娠治疗中的价值。方法选取我院在2013年9月～2015年9月收治的60例内生型早期剖宫产瘢痕妊娠患者为研究对象，随机分成治疗组和对照组，对照组采取甲氨蝶呤治疗，治疗组在此基础上联合米非司酮治疗，分析治疗效果。结果治疗组总有效率高于对照组，差异具有统计学意义（P＜0.05）。结论对于内生型早期剖宫产瘢痕妊娠患者而言，采取甲氨蝶呤联合米非司酮进行治疗效果显著，临床价值较高。